省级脏药房计划的结构和功能:应用慢性护理模式来解决公平获得药物和药房服务的问题
Elnaz Roohi1, Clifford Lo2,3, Dan Martinusen2,3,4
1Department of Experimental Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, Canada.
Canadian journal of kidney health and disease
|June 14, 2023
概括
本研究概述了加拿大不列颠哥伦比亚省的一项省级药房计划,确保所有患者平等获得病药物和药房服务. 该计划利用一个结构化的网络,在全省提供全面的护理.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 药房实践 在药房实践.
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 脏疾病需要专门和一致的药房服务.
- 在地理上多样化的地区,公平地获得药物和药房护理仍然是一个挑战.
- 现有的医疗保健模式往往缺乏针对慢性疾病的综合药房支持.
研究的目的:
- 描述不列颠哥伦比亚省 (BC) 病患者的省级药房服务网络的理由,结构,设计和组件.
- 将这个网络作为一个模型,在各种临床条件和地理区域实现公平的获取和普遍的药房护理.
- 详细介绍该计划在现有省级医疗保健基础设施中的整合.
主要方法:
- 审查了广泛的文档,包括药房服务和表单 (PS&F) 委员会会议记录 (1999-2022) 和不列颠哥伦比亚脏 (BCR) 网站数据.
- 直接观察和参与委员会会议.
- 慢性护理模型 (CCM) 的定性主题综合,以将程序组件置于背景.
- 采访主要项目利益相关者.
主要成果:
- 省级药房计划 (PPP) 包括一个PS&F委员会,标准化的社区药房,一个专门的预算,省级药品合同,沟通/教育举措和信息管理系统.
- 针对不同阶段的病患者,包括透析和非透析患者,存在专门的配方药.
- 通过社区和医院药房的分布式网络,促进对所有药物和咨询服务的平等获取.
- 中央化的省级合同和问责制结构确保了成本效益和可持续性.
结论:
- 描述的省级药房计划 (PPP) 是BC基础设施的组成部分,确保为病患者提供必要的药物和药房服务.
- 该计划在利用当地和省级资源方面取得的成功表明了透明和负责任的模式.
- 这种全面的PPP可以作为其他司法管辖区寻求改善药房准入和治疗慢性疾病的可复制模型.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
50
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
50
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
99
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
99
01:17Factors Affecting Renal Clearance: Renal Impairment
123
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
123
01:06Three-Compartment Open Model
291
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
291
01:25Chronic Kidney Disease I: Introduction
43
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
43
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
99
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
99